Company Sight Sciences, Inc.

Equities

SGHT

US82657M1053

Medical Equipment, Supplies & Distribution

Delayed Nasdaq 16:00:00 2024-05-24 EDT 5-day change 1st Jan Change
5.57 USD +5.49% Intraday chart for Sight Sciences, Inc. +4.31% +7.95%

Business Summary

Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma and the SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids in adult patients with evaporative dry eye disease due to meibomian gland disfunction.

Number of employees: 214

Sales per Business

USD in Million2022Weight2023Weight Delta
Surgical Glaucoma
91.7 %
66 92.0 % 74 91.7 % +13.29%
Dry Eye
8.3 %
6 8.0 % 7 8.3 % +17.59%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
71 100.0 % 81 100.0 % +13.63%

Managers

Managers TitleAgeSince
Founder 54 09-12-31
Founder 49 09-12-31
Director of Finance/CFO 42 23-04-02
Compliance Officer - 20-10-31
Chief Tech/Sci/R&D Officer - 19-03-31
Chief Tech/Sci/R&D Officer - 11-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 63 20-02-29
General Counsel - 21-07-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 56 20-05-31
Director/Board Member 61 19-10-31
Founder 49 09-12-31
Director/Board Member 64 22-03-14
Chairman 72 16-12-31
Founder 54 09-12-31
Director/Board Member 59 23-06-07
Director/Board Member 61 22-07-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 49,756,252 39,495,687 ( 79.38 %) 0 79.38 %

Shareholders

NameEquities%Valuation
Allegro Investment, Inc.
12.55 %
6,218,526 12.55 % 32 M $
5,155,004 10.40 % 26 M $
KCK-US, Inc.
9.377 %
4,646,866 9.377 % 24 M $
Bank of America, NA (Charlotte, North Carolina)
6.382 %
3,162,403 6.382 % 16 M $
UBS Group AG (13f Subfiler)
5.795 %
2,871,756 5.795 % 15 M $
2,259,777 4.560 % 12 M $
Jackson Square Partners LLC
3.249 %
1,609,922 3.249 % 8 M $
1,602,444 3.234 % 8 M $
Vanguard Fiduciary Trust Co.
3.141 %
1,556,450 3.141 % 8 M $
BlackRock Advisors LLC
2.777 %
1,375,902 2.777 % 7 M $

Company contact information

Sight Sciences, Inc.

4040 Campbell Avenue Suite 100

94025, Menlo Park

+

http://www.sightsciences.com
address Sight Sciences, Inc.(SGHT)
  1. Stock Market
  2. Equities
  3. SGHT Stock
  4. Company Sight Sciences, Inc.